NLM Digital Collections

Search

Start Over Languages English ✖Remove constraint Languages: English Copyright Public domain ✖Remove constraint Copyright: Public domain Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later Publication Year 2019 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2019">2019</span>

141. Most hospitals obtain compounded drugs from outsourcing facilities, which must meet FDA quality standards

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2019
Subject(s):
Drug Compounding -- standards
Medicare
Outsourced Services
Purchasing, Hospital
Quality Control
Chemistry, Pharmaceutical -- standards
Humans
United States
United States. Food and Drug Administration.

142. Part D plans generally include drugs commonly used by dual eligibles: 2019

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2019
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Insurance Coverage
Medicare Part D -- economics
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Medicare -- economics
Humans
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

144. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States

146. ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Accountable Care Organizations -- economics
Cost Savings
Medicare -- economics
Quality of Health Care
Value-Based Purchasing
Cost Sharing
Electronic Health Records
Health Information Exchange
Home Care Services
Hospitalization
Mental Health Services
Multiple Chronic Conditions
Patient Transfer
Reimbursement Mechanisms
Skilled Nursing Facilities
Social Determinants of Health
Humans
United States

149. Many Medicaid-enrolled children who were treated for ADHD did not receive recommended followup care

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2019
Subject(s):
Aftercare
Attention Deficit Disorder with Hyperactivity -- drug therapy
Attention Deficit Disorder with Hyperactivity -- therapy
Follow-Up Studies
Medicaid
Behavior Therapy
Child
Medication Therapy Management
Quality Indicators, Health Care
Humans
United States

150. Medicare Part B drug payments: impact of price substitutions based on 2017 average sales prices

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2019
Subject(s):
Cost Control
Cost Savings
Drug Costs
Insurance, Health, Reimbursement
Medicare Part B -- economics
Reimbursement Mechanisms
Economics, Pharmaceutical
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)